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Abstract
Unique purine-rich mRNA sequences embedded in the coding sequences of a distinct group of gammaherpesvirus
maintenance proteins underlie the ability of the latently infected cell to minimize immune recognition. The Epstein-Barr
virus nuclear antigen, EBNA1, a well characterized lymphocryptovirus maintenance protein has been shown to inhibit in cis
antigen presentation, due in part to a large internal repeat domain encoding glycine and alanine residues (GAr) encoded by
a purine-rich mRNA sequence. Recent studies have suggested that it is the purine-rich mRNA sequence of this repeat region
rather than the encoded GAr polypeptide that directly inhibits EBNA1 self-synthesis and contributes to immune evasion. To
test this hypothesis, we generated a series of EBNA1 internal repeat frameshift constructs and assessed their effects on cis-
translation and endogenous antigen presentation. Diverse peptide sequences resulting from alternative repeat reading
frames did not alleviate the translational inhibition characteristic of EBNA1 self-synthesis or the ensuing reduced surface
presentation of EBNA1-specific peptide-MHC class I complexes. Human cells expressing the EBNA1 frameshift variants were
also poorly recognized by antigen-specific T-cells. Furthermore, a comparative analysis of the mRNA sequences of the
corresponding repeat regions of different viral maintenance homologues highlights the high degree of identity between
the nucleotide sequences despite very little homology in the encoded amino acid sequences. Based on these combined
observations, we propose that the cis-translational inhibitory effect of the EBNA1 internal repeat sequence operates
mechanistically at the nucleotide level, potentially through RNA secondary structural elements, and is unlikely to be
mediated through the GAr polypeptide. The demonstration that the EBNA1 repeat mRNA sequence and not the encoded
protein sequence underlies immune evasion in this class of virus suggests a novel approach to therapeutic development
through the use of anti-sense strategies or small molecules targeting EBNA1 mRNA structure.
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Introduction
Members of the viral family Herpesviridae, which are widely
distributed throughout the animal kingdom, are characterized by
their large double-stranded, linear DNA genomes. The gamma-
herpesviruses, one of three sub-families of Herpesviridae, predom-
inantly replicate and persist in lymphoid cells with the distin-
guishing characteristic that they are able to establish lifelong latent
infections of their hosts [1].
Gammaherpesviruses are of particular interest mainly due to
the two human viruses, Epstein-Barr virus (EBV) and Kaposi’s
sarcoma-associated herpes virus, (KSHV) and the diseases they
cause; Burkitts lymphoma, Nasopharyngeal carcinoma and
Hodgkins lymphoma in the case of EBV and Kaposi’s sarcoma,
primary effusion lymphomas and AIDS-related lymphoprolifera-
tive disorders in the case of KSHV [2–4]. Latent infection of host
cells by many gammaherpesviruses is dependent upon the
expression of a viral maintenance protein, which ensures
persistence of the viral episome within actively dividing cells, yet
simultaneously evades immune surveillance [5–8]. Recent studies
have investigated the unique properties of gammaherpesvirus
maintenance proteins that allow the virus to restrict detection by
host CD8+ cytotoxic T lymphocytes (CTLs) at crucial times during
latency [1,9–16].
Expression of the EBV nuclear protein 1 (EBNA1) is widespread
in all forms of EBV infection, accentuating its central role in the
maintenance of the viral DNA episome, a process essential for viral
persistence and associated oncogenic potential [17,18]. A wide
range of studies have demonstrated that EBV latently infected B
cells are able to escape immune recognition, due in part to an
internal glycine–alanine repeat (GAr) domain within EBNA1,
which significantly limits MHC class I-restricted presentation of
EBNA1 epitopes linked in cis [9–15,19–22]. An earlier report
suggested that the GAr polypeptide directly interfered with the
translational machinery [10]. However, more recent studies
including reports from the Hoeben group, have proposed that
the EBNA1 purine-rich mRNA secondary structure encoding the
GAr, rather than the protein sequence, is the critical component
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underlying the regulation of self-synthesis and evasion of immune
recognition by cytotoxic T-cells [9,11,12,15,22].
Similar to EBNA1, the latency-associated nuclear antigen 1
(LANA1) maintenance protein of the closely related KSHV virus
also acts to tether the viral episome to the host genome, thereby
permitting the necessary segregation of viral DNA during cell
division [9,15]. Studies have also demonstrated that LANA1
inhibits MHC class I peptide presentation in cis as a means of
immune evasion [9,15]. Interestingly, studies of several other
members of the gammaherpesvirus family have also reported
similar immune evasive properties for the maintenance proteins of
these viruses [23,24].
To define the underlying mechanism influencing the cis-
translational inhibition responsible for minimizing the exposure
of EBNA1 epitopes to immune surveillance, we have designed a
series of EBNA1 expression constructs encoding alternative repeat
reading frames to assess their impact on self-synthesis and antigen
presentation. As well as these genetic experiments, we have also
undertaken a detailed comparative analysis of the mRNA and
protein sequences of the repeat regions of different gammaher-
pesvirus maintenance protein homologues. Based on these
analyses, we conclude that the cis-inhibitory effect of the internal
repeat sequences of gammaherpesviruses operates at the nucleo-
tide level and is unlikely to be mediated through the direct action
of the GAr polypeptide.
Results
Comparative analysis of the mRNA sequences encoding
different gammaherpesvirus maintenance proteins
The internal GAr sequence within the EBV maintenance
protein, EBNA1, has been shown to inhibit self-synthesis, which in
turn significantly restricts in cis antigen presentation [10–14,19–
22]. To assess the functional importance of the mRNA sequence
versus the protein sequence of the EBNA1 internal repeat in
inhibiting self-synthesis, we compared both the mRNA and
encoded protein sequences of similar internal repeat structures
within the viral maintenance proteins of several gammaherpes-
viruses. Similar to EBNA1, these maintenance proteins are critical
for the persistence of the viral genome within latently infected cells.
Gammaherpesviruses have been subdivided into four genera:
Lymphocryptovirus, Rhadinovirus, Macavirus and Percavirus (Table 1)
[25]. Lymphocryptoviruses (LCVs) include the well-characterized
EBV or Human herpesvirus 4 [26,27], Lymphocryptovirus of rhesus
monkeys, and Herpesvirus papio of baboons [26,28,29]. The
Rhadinoviruses include the second human gammaherpesvirus
KSHV or Human herpesvirus 8 [30,31], Herpesvirus saimiri (HVS)
[32] and Rhesus monkey rhadinovirus (RRV) [33]. The genera
Macavirus includes the Alcelaphine herpesvirus 1 [34] and a newly
defined species [25] the Ovine herpesvirus 2 (Table 1) [35]. The
coding mRNA sequence and deduced protein sequence of the viral
maintenance proteins of these gammaherpesviruses were extracted
from GenBank [36].
The overall homology between the EBNA1 coding mRNA
sequence and coding mRNAs for different gammaherpesvirus
maintenance proteins was investigated by performing mRNA dot-
plot pair wise sequence alignments [37] to visualize local
alignments of repeated regions between the maintenance protein
homologues and EBNA1 (Fig. 1). The over-all homology between
sequences is shown as a straight line on the diagonal, while regions
of repeats are shown as lots of lines in the same region, allowing
visualization of where the repeated regions are between sequences.
In each panel the intensity of the dot plots indicate the level of
homology between the sequences being compared. As illustrated
in Figure 1, the EBNA1 internal mRNA repeat sequence is highly
identical to regions of similar repeat sequences, albeit in different
positions within the coding sequences of the maintenance proteins
from other gammaherpesviruses. The plot in Panel A highlights a
highly repetitive homologous region between Human Herpes virus 4
EBNA1 (280–1180 bp) and Human Herpes virus 8 LANA1 (1000–
2800 bp), while Panel B highlights a highly repetitive homologous
region towards the 59 ends of both the Human Herpes virus 4 EBNA1
(280–1180 bp) and Papiine Herpes virus 1 baboon EBNA1 (290–
580 bp) sequences. All six viral maintenance protein mRNAs
showed varying sized repeated regions that have strong homology
with the internal repeat present within the EBNA1 mRNA. In
Table 1 it is apparent that the identity between these purine-rich
mRNA repeat sequences of EBNA1 and other viral maintenance
proteins is relatively high (50–75.6%), whilst strikingly the
corresponding repeat amino acid sequences showed markedly
reduced identity levels and in some cases the complete absence of
any similar conservation. For example, there is less than 1%
homology between Human Herpes virus 4 EBNA1 and Human Herpes
virus 8 LANA1 repeat amino acid sequences and only 2.1%
homology between Human Herpes virus 4 EBNA1 and Macacine
herpesvirus 5 Rhesus rhadinovirus ORF73 repeat amino acid
sequences, despite corresponding repeat mRNA identities of
76.2% and 66.5%, respectively.
EBNA1 gene constructs expressing diverse protein repeat
sequences but near identical mRNA sequences
Three EBNA1 expression constructs were designed comprising
identical mRNA sequences whilst encoding three, alternative
repeat reading frames. The constructs were used to assess the
impacts of the EBNA1 repeat region mRNA and protein sequence
on self-synthesis and antigen presentation. Three DNA fragments
were synthesized to generate the alternative EBNA1 repeat
reading frames encoding either glycine/alanine residues, referred
Author Summary
Viruses establishing persistent latent infections have
evolved various mechanisms to avoid immune surveil-
lance. The Epstein-Barr virus-encoded nuclear antigen,
EBNA1, expressed in all EBV-associated malignancies,
modulates its own protein levels at quantities sufficient
to maintain viral infection but low enough so as to
minimize an immune response by the infected host cell.
This evasion mechanism is regulated through an internal
purine-rich mRNA repeat sequence encoding glycine and
alanine residues. In this study we assess the impact of the
repeat’s nucleotide versus peptide sequence on inhibiting
EBNA1 self-synthesis and antigen presentation. We dem-
onstrate that altered peptide sequences resulting from
frameshift mutations within the repeat do not alleviate the
immune-evasive function of EBNA1, suggesting that the
repetitive purine-rich mRNA sequence itself is responsible
for inhibiting EBNA1 synthesis and subsequent poor
immunogenicity. Our comparative analysis of the mRNA
sequences of the corresponding repeat regions of different
gammaherpesvirus maintenance homologues to EBNA1
highlights the high degree of identity between the
nucleotide sequences despite very little homology in the
encoded amino acid sequences. These studies demon-
strate the importance of gammaherpesvirus purine-rich
mRNA repeat sequences on antigenic epitope generation
and evasion from T-cell mediated immune control,
suggesting novel approaches to prevention and treatment
of latent infection by this class of virus.
mRNA Sequence Influences EBNA1 MHC I Presentation
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to as E1-GA(wild-type); glycine/glutamine/glutamic acid residues,
referred to as E1-GQE(frameshift 1); or glycine/arginine/serine,
referred to as E1-GRS(frameshift 2). The synthesized DNA fragments
were cloned into an EBNA1 expression construct lacking the internal
GAr sequence (E1DGA/pcDNA3) to generate the EBNA1 protein
sequences outlined in Figure 2. This strategy maintained the wild-
type protein sequences in the regions flanking the internal repeat. As
illustrated in Figure 2, a single nucleotide deletion near the start of the
EBNA1 repeat sequence generated a strongly acidic (GQE) repeat
domain, whilst the deletion of two nucleotides at the same position
resulted in a third repeat reading frame encoding a repetitive peptide
with both basic and neutral residues (GRS). The corresponding
insertion of either one or two nucleotides at the end of the repeat
sequence allowed the contiguous encoded C-terminal domains for
these constructs to maintain wild-type EBNA1 protein sequence
(Figure S1 in Text S1). Thus, the three proteins generated by these
constructs were highly dissimilar in their repeat regions in terms of
amino acid composition and charge.
For intracellular localization studies, the EBNA1 frameshift
expression sequences were also sub-cloned in-frame with a sequence
coding for green fluorescent protein, generating fusion proteins with
GFP at the C-terminus. In addition, the H-2Kb-restricted SIINFEKL
epitope from ovalbumin, was inserted in-frame into the different
EBNA1-GFP frameshift variants for endogenous processing studies
thereby generating the following expression constructs E1DGA-SIIN-
GFP, E1-GA(wild-type)-SIIN-GFP, E1-GQE(frameshift 1)-SIIN-
GFP and E1-GRS(frameshift 2)-SIIN-GFP. A microscopic analysis
presented in Figure 3 (panels A and B) demonstrated an unaltered
nuclear staining pattern for all three EBNA1-SIIN-GFP frameshift
variants as well as for E1DGA-SIIN-GFP, which lacks the internal
repeat. Whilst constructs encoding the wild-type GA repeat or GQE
repeat resulted in similar expression levels following transfection,
there was reduced EBNA1-GFP expression for the construct
encoding GRS repeat sequences (Fig. 3, panel A). The reduced
expression of E1-GRS(frameshift 2)-SIIN-GFP transfectants was not
due to differential transfection efficiencies as all three alternative
reading frame constructs contain virtually identical DNA sequences
which differ by only one or two nucleotides. The lower expression of
E1-GRS(frameshift 2)-SIIN-GFP transfectants was consistent with
decreased cell viability observed in the phase contrast microscopic
analysis of the GRS transfectants (Figure 3, panel C), demonstrating a
reduced percentage of GFP-expressing cells following transfection.
Also of note, the GFP+ve GRS-transfectants are very low GFP
expressers (MFI of 705) compared to an MFI of 4692 for the EBNA1
wild-type transfectants and 11,385 for E1DGA transfectants,
indicating less EBNA1-GFP is being synthesized in GRS transfectants
(Figure 3 panel D) and possibly resulting in a percentage of the GRS
GFP-expressing cells being below the threshold level for GFP
detection. Expression levels of the EBNA1-SIIN-GFP frameshift
variants were also confirmed by flow cytometry (Fig. 3, panel D).
Thus, the three EBNA1-GFP frameshift variants are all expressed
and demonstrate similar nuclear localization.
Alternative EBNA1 repeat peptide sequences display
similar intracellular degradation kinetics and do not lead
to increased EBNA1 expression
To discount the possibility that altered peptide sequences due to
alternative reading frames within the EBNA1 repeat domain may
Table 1. Homologies among gammaherpesvirus maintenance proteins.
Gammaherpesviruses
Viral
maintenance
protein
homologues
Internal mRNA
repeat size (bp)
Purine content
of the
mRNA repeats (%)
Identity of the
nucleotide sequence
repeat in EBNA1 with
nucleotide repeats in
other viral
maintenance protein
homologues (%)
Homology2 of the
protein sequence
repeat in EBNA1 with
repeats in other viral
maintenance protein
homologues (%)
Lymphocryptoviruses
Human herpesvirus 4 EBNA1 711 88.1 100 100
Macacine herpesvirus 4 rhEBNA1 141 78.0 70.2 46.8
Papiine herpesvirus 1 baEBNA1 49 80.9 75.6 55
Rhadinoviruses
Human herpesvirus 8 LANA1 CR11 1818 76.2 52 0.3
CR2 50 0.3
CR3 72 0.4
Macacine herpesvirus 5 ORF73 1554 66.5 57.1 2.1
Saimirine herpesvirus 2 ORF73 546 85.3 58.5 17.6
Macaviruses
Alcelaphine herpesvirus1 ORF73 CR1 2061 96.6 56.6 29.5
CR2 62.6 0
CR3 74 50
Ovine herpesvirus 2 ORF73 CR1 984 85.7 65.8 40.8
CR2 64 0
CR3 68.4 44
1CR 1–3 designates sub-regions of internal central repeats displaying varying peptide sequences.
2Homology data for protein sequences was acquired using the Strider sequence alignment program that uses the BLOSUM62 score matrix to score pairs of aligned
residues [42].
doi:10.1371/journal.ppat.1003112.t001
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have changed protein stability, we determined the intracellular
kinetics of degradation of the EBNA1-SIIN-GFP frameshift
variants following cycloheximide treatment of 293KbC2 cells
transiently transfected with E1DGA-SIIN-GFP, E1-GA(wild-
type)-SIIN-GFP, E1-GQE(frameshift 1)-SIIN-GFP, E1-GRS(fra-
meshift 2)-SIIN-GFP or E1DGA-SIIN-GFP expression constructs
(in the presence or absence of 10 mM of the proteasomal inhibitor
MG132) over a 30 hour time course. Both the E1-GA(wild-type)-
SIIN-GFP and E1-GQE(frameshift 1)-SIIN-GFP transfectants
displayed a similar pattern of degradation (Fig. 4A) which was
slightly lower than that observed for E1DGA-SIIN-GFP trans-
fectants. The E1-GRS(frameshift 2)-SIIN-GFP transfectants
displayed a less pronounced decrease in EBNA1-SIIN-GFP
expression at 24 hours (Fig. 4A). The degradation kinetics
carried out in the presence of the proteasomal inhibitor
MG132 demonstrate that the observed loss of EBNA1-GFP
fluorescence following cycloheximide treatment is due to turnover
(Figure 4A).
In vitro translation assays of the EBNA1/pcDNA3 frameshift
variants demonstrated similarly low translational efficiencies for
EBNA1 sequences encoding either GQE or GRS repeat domains
as observed for the wild-type GA repeat domain (Fig. 4B). In
contrast, the translational efficiency of the EBNA1 sequence
lacking the internal repeat domain, E1DGA, is 10-fold higher
(p,0.05) (Fig. 4B). The different migration rates observed for the
EBNA1 frameshift variants is due to the nature of the highly
repeated residues within the frameshift repeat domains leading to
varying amounts of bound SDS per unit mass of protein. The
strongly acidic protein, E1-GA(GQE), binds less SDS and hence
migrates slower than expected. The E1-GA(GRS) protein is
strongly basic and binds excess SDS causing the protein to migrate
faster than expected. All of the expression constructs containing
the purine-rich repeat also display premature termination products
arising from the difficulty in ribosome transit through this
sequence. In summary, neither of the two frameshift variants
E1-GA(GQE) or E1-GA(GRS) were able to override the
translational inhibition observed for the EBNA1 sequence
encoding the wild-type GA repeat domain.
Impact of repeat frameshifts on the endogenous
processing of EBNA1 CD8+ T-cell epitopes
Several experiments were undertaken to examine the impact of
alternative EBNA1 repeat peptide sequences on the endogenous
processing of MHC class I-restricted epitopes within EBNA1. In
the first set of experiments, the endogenous loading of MHC class
I molecules with a H-2Kb-restricted epitope from ovalbumin
(SIINFEKL residues 257–264) inserted at the C-terminus of the
EBNA1 sequence was assessed [11]. H-2Kb expressing HEK293
cells were transiently transfected with either E1-GA(wild-type)-
SIIN-GFP, E1DGA-SIIN-GFP, E1-GQE(frameshift 1)-SIIN-GFP
or E1-GRS(frameshift 2)-SIIN-GFP expression constructs with
transfection efficiencies of 47%, 50%, 42.8% and 8% respectively.
Following transfection (24 h), cells were assessed by flow cytometry
for GFP expression and surface expression of H-2Kb-SIINFEKL
complexes using a monoclonal antibody (25-D1.16) that recog-
nizes the SIINFEKL epitope bound to H-2Kb molecules [38].
Flow cytometry results shown in Figure 5 demonstrate that the
percentage of cells expressing surface H-2Kb-SIINFEKL com-
plexes was similar for all three EBNA1 repeat reading frames and
ranged from 1.9%–2.0%. In contrast, a 4–4.3-fold increase in the
surface expression of H-2Kb-SIINFEKL complexes was observed
for transfectants expressing EBNA1-GFP lacking the GAr domain
(E1DGA-SIIN-GFP), indicating that all three repeat reading
frames inhibited the endogenous processing of MHC class I-
restricted epitopes within EBNA1 to a similar extent (Fig. 5).
Transfection of a control parent plasmid without SIINFEKL
provided a baseline (0.67% cells expressing surface H-2Kb-
SIINFEKL complexes) above which an increase in fluorescence
would indicate specific surface expression of H-2Kb-SIINFEKL
complexes.
Figure 1. Dot-plot analyses illustrating pair wise local alignments between the EBNA1 mRNA sequence and the mRNAs for several
gammaherpesvirus maintenance protein sequences. The over-all homology between sequences is shown as a straight line on the diagonal,
while regions of repeats are shown as lots of lines in the same region, allowing visualization of where the repeated regions are between sequences.
Panel A, Nucleotide sequence homology between human herpesvirus-4, (HHV-4) EBNA1 and human herpesvirus-8 (HHV-8) LANA1; Panel B, (Papiine
herpesvirus-1, HV-1) baboon EBNA1; Panel C, (Macacine HV-4) rhesus EBNA1; Panel D, (Alcelaphine HV-1) ORF73; Panel E, (Ovine HV-2) ORF73, and;
Panel F, (Samirine HV-2) ORF73. In each panel the intensity of the dot plots indicate the level of homology between the sequences being compared.
Transcript sizes are shown in kb on both axes. The Genbank accessions numbers for these sequences are listed in the Materials and Methods.
doi:10.1371/journal.ppat.1003112.g001
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In the next set of experiments, the influence of EBNA1 repeat
frameshifts on the T-cell recognition of a H-2Kb-restricted
SIINFEKL epitope encoded within EBNA1 was evaluated. H-
2Kb expressing HEK293 cells were transiently transfected with
either E1-GA(wild-type)-SIIN-GFP, E1DGA-SIIN-GFP, E1-
GQE(frameshift 1)-SIIN-GFP or E1-GRS(frameshift 2)-SIIN-
GFP expression constructs with transfection efficiencies of
45.5%, 49%, 43% and 9.8%, respectively. Twenty-four hours
post-transfection, cells were incubated with CD8+ T-cells specific
for the SIINFEKL epitope and stimulation was assessed by
intracellular cytokine staining assays (ICS). Data presented in
Figure 6 (panels A and B) show that both E1-GA(wild-type)-SIIN-
GFP and E1-GQE(frameshift 1)-SIIN-GFP transfectants stimulat-
ed a similar number of IFN-c producing SIINFEKL-specific T-
cells (4.2% and 4.4%, respectively). Transfectants expressing E1-
GRS(frameshift 2)-SIIN-GFP stimulated 4-fold less IFN-c pro-
ducing SIINFEKL-specific T-cells (1.1%) than transfectants
expressing GA(wild-type)-SIIN-GFP or GQE(frameshift 1)-SIIN-
GFP, consistent with reduced EBNA1 expression levels following
transfection of EBNA1-GFP constructs expressing repeat sequenc-
es encoding GRS residues. Cells expressing EBNA1-GFP lacking
the GAr domain (E1DGA-SIIN-GFP) stimulated 2–2.1-fold more
IFN-c producing SIINFEKL-specific T-cells (8.9%) compared to
GA(wild-type) (4.2%) or GQE(frameshift 1) (4.4%) repeat domains
(Fig. 6, panels A and B).
The endogenous processing of a second CD8+ T-cell epitope,
this time encoded within EBNA1 (HLA B*3508-restricted,
HPVGEADYFEY residues 407–417) was similarly assessed.
EBV-negative DG75 B-cells were transiently co-transfected with
E1DGA-SIIN-GFP or EBNA1-GFP expression vectors encoding
alternative EBNA1 repeat peptide sequences; E1-GA(wild-type)-
SIIN-GFP, E1-GQE(frameshift 1)-SIIN-GFP, E1-GRS(frameshift
2)-SIIN-GFP and a HLA B*3508-GFP expression construct.
Transfection efficiencies were similar for all constructs ranging
from 63.2%–68.8%. Co-transfection with the HLA B*3508-GFP
expression construct allowed evaluation of endogenous processing
of EBNA1 using HPV-specific T-cell clones. At twenty-four hours
post-transfection, cells were incubated with CD8+ T-cells specific
for HPV epitopes and stimulation assessed using ICS. Data
presented in Figure 6 (panels C and D) demonstrate that cells
expressing E1-GQE(frameshift 1)-SIIN-GFP or E1-GRS(frame-
shift 2)-SIIN-GFP showed no increased stimulation of IFN-c
producing HPV-specific T-cells compared to cells expressing E1-
GA(wild-type)-SIIN-GFP. This result was identical to our earlier
Figure 2. Schematic description of EBNA1 expression constructs containing identical mRNA sequences whilst encoding alternative
repeat reading frames. A, The EBNA1 frameshift constructs were generated in either pcDNA3 for in vitro translation studies or in pEGFP-N1 for
EBNA1-GFP expression and immunological studies. The overlapping DNA binding and dimerization domain, nuclear localization signal (NLS) and
Glycine/Arginine (GR) repeat flanking sequences essential for genome maintenance functions are shown. The localizations of a model SIINFEKL
epitope and the endogenous EBNA1 HPVGEADYFEY epitope used in the presentation assays are highlighted. B, Alignment of amino acid sequences
of the EBNA1 (E1) repeat frameshift variants E1-GA(wild-type), E1-GQE(frameshift 1) and E1-GRS(frameshift 2). An asterisk indicates identical residues
in all three proteins. Arrows denote nucleotide deletion positions at the start of the internal repeat and nucleotide insertion positions at the ends of
the repeat in the E1-GA(wild-type) sequence to generate alternative repeat reading frames whilst maintaining wild-type EBNA1 sequence at both the
N- and C-terminal domains flanking the internal repeat sequence.
doi:10.1371/journal.ppat.1003112.g002
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endogenous processing and presentation data with the SIINFEKL
epitope. Collectively, the endogenous processing results demon-
strate that the poor immunogenicity of EBNA1 is unlikely to be
due to the alanine/glycine repetitive peptide sequence within the
EBNA1 repeat since alternative repeat peptide sequences also
failed to enhance the presentation of MHC class I-restricted
epitopes within EBNA1 to the level observed for cells expressing
E1DGA-SIIN-GFP, where the GAr had been deleted.
Impact of the Ateline herpesvirus 3 ORF73 repeat mRNA
on EBNA1 expression and T-cell recognition
To assess the impact of a purine-rich repeat sequence from
another gammaherpesvirus maintenance protein on both EBNA1
expression and T-cell recognition of a SIINFEKL epitope fused to
EBNA1, a 519 nucleotide repeat sequence from the Ateline herpesvirus
3 ORF73 was synthesized and cloned into the E1DGA-SIIN-GFP
expression vector to generate (E1-Ateline-SIIN-GFP). The resulting
EBNA1-Ateline expression vectors encoded a 173 amino acid acidic
repeat domain of predominantly glycine and aspartic acid (GD)
residues (Figure S2 in Text S1). A microscopic analysis presented in
Figure 7A demonstrated the expected nuclear staining pattern for
the E1-Ateline-SIIN-GFP variant, similar to the EBNA1 wild-type
and frameshift variants. Following transfection of the E1-Ateline-
SIIN-GFP expression construct, we observed a notably reduced
EBNA1-SIIN-GFP expression level, as evidenced by an MFI of
1224 (Fig. 7A), which was 9 fold lower than the MFI for E1DGA-
SIIN-GFP and 3.5 fold lower than the MFI observed for E1-
GA(wild-type)-SIIN-GFP (Fig. 3 panel D).
Next, the influence of the Ateline herpesvirus 3 repeat sequence in
the context of EBNA1 on T-cell recognition of the H-2Kb-
restricted SIINFEKL epitope fused to EBNA1 was also evaluated.
H-2Kb expressing HEK293 cells were transiently transfected with
either E1-Ateline-SIIN-GFP, E1DGA-SIIN-GFP or E1-GA(wild-
type)-SIIN-GFP expression constructs. Twenty-four hours post-
transfection, cells were incubated with CD8+ T-cells specific for
the SIINFEKL epitope and stimulation assessed by intracellular
cytokine staining assays. Data presented in Figure 7B demonstrate
that E1-Ateline-SIIN-GFP transfectants stimulated only 1.2% of
IFN-c producing SIINFEKL-specific T-cells compared to 4.04%
for E1-GA(wild-type)-SIIN-GFP transfectants and 7.59% for
E1DGA-SIIN-GFP transfectants, at a responder:stimulator ratio
of 2.5:1. This result is consistent with the reduced EBNA1-SIIN-
GFP expression levels observed for E1-Ateline-SIIN-GFP trans-
fectants in Figure 7A and demonstrates that the purine-rich
mRNA repeat of the Ateline herpesvirus 3 ORF73 is able to inhibit
both protein expression and T-cell recognition.
Discussion
Viruses that establish chronic latent infections of host cells have
evolved numerous mechanisms to evade the host immune system.
One such example is the Epstein-Barr virus nuclear antigen 1,
EBNA1, which is responsible for maintenance of the viral episome
within latently infected B cells. The synthesis of EBNA1 is tightly
regulated to achieve levels sufficient to maintain viral infection, but
low enough so as to minimize EBNA1’s exposure to EBNA1-
specific T-cells.
Figure 3. Localization and expression of EBNA1-SIIN-GFP frameshift constructs. Panel A, GFP fluorescence of EGFP-N1, E1-GA(wild-type)-
SIIN-GFP, E1DGA-SIIN-GFP, E1-GQE(frameshift 1)-SIIN-GFP or E1-GRS(frameshift 2)-SIIN-GFP expression constructs in 293KbC2 cells. The cells were
examined using a laser-scanning Bio-Rad (Hercules, CA) MRC600 confocal microscope with original magnification663. Panel B, DAPI staining, and;
Panel C, phase contrast images of the EBNA1-SIIN-GFP transfected cells. Panel D, Flow cytometric analysis of GFP expression in 293KbC2 cells
following transfection with EGFP-N1 or EBNA1-SIIN-GFP frameshift variants. The Mean Fluorescence Intensity (MFI) of the EBNA1-GFP positive cells is
indicated in the top right hand corner of each plot.
doi:10.1371/journal.ppat.1003112.g003
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The regulated inhibition of EBNA1 synthesis has been shown to
occur in cis as a result of an internal purine-rich repetitive mRNA
sequence that dramatically reduces the rate of EBNA1 protein
synthesis [12]. Removal of the repeat sequence leads to increased
EBNA1 synthesis and enhanced recognition of MHC class I-
restricted epitopes within EBNA1. The current studies demon-
strate that this regulated inhibition of EBNA1 synthesis and the
resultant restriction of antigen presentation and host immune
recognition is independent of alternative repeat protein sequences
embedded in EBNA1 mRNA. Combined microscopic analyses, in
vitro translation assays and intracellular cytokine presentation
experiments, investigating frameshift changes within the EBNA1
internal repeat demonstrate that altered peptide sequences within
the repeat do not override the repeat’s cis-inhibitory effect on
Figure 4. Intracellular degradation kinetics and expression of alternative EBNA1 repeat peptide sequences. A, 293KbC2 cells were
transfected with the following expression constructs E1DGA-SIIN-GFP; E1-GA(wild-type)-SIIN-GFP; E1-GQE(frameshift 1)-SIIN-GFP or E1-GRS(frameshift
2)-SIIN-GFP in the presence or absence of the proteasome inhibitor MG132 (10 mM). At 24 h post-transfection, the cells were incubated with
cycloheximide (50 mg/ml) and then monitored over a 30-h time course as described in the Materials and Methods. EBNA1-SIIN-GFP expression of the
cells at each time point was monitored by flow cytometry and plotted as the relative change in the levels of EBNA1-GFP expression following the
addition of cycloheximide at time point 0. B, In vitro translation (IVT) assay of pcDNA3 expression constructs encoding E1DGA (lane 1), E1-GA(wild-
type) (lane 2), E1-GQE(frameshift 1) (lane 3) or E1-GRS(frameshift 2) (lane 4).The constructs were transcribed and translated in vitro with T7 RNA
polymerase by using a coupled transcription/translation reticulocyte lysate system. 35S-methionine-labeled proteins were visualized by
autoradiography (upper panel). An asterisk indicates the full-length translation product of each EBNA1 frameshift variant. Band intensities from
the IVT assay were quantified by densitometric analysis using Imagequant software (Molecular Dynamics) and graphed to demonstrate absolute
intensities (lower panel). These data are representative of three separate experiments.
doi:10.1371/journal.ppat.1003112.g004
Figure 5. Detection of H-2Kb–SIIN complexes on the surface of 293KbC2 cells expressing EBNA1-SIIN-GFP frameshift variants. H-
2Kb–SIIN expression was assessed by flow cytometry of 293KbC2 cells transfected with E1-GA(wild-type)-SIIN-GFP, E1DGA-SIIN-GFP, E1-
GQE(frameshift 1)-SIIN-GFP or E1-GRS(frameshift 2)-SIIN-GFP following staining with the monoclonal antibody 25D1.16 conjugated to
Allophycocyanin [38]. Values shown in each FACS plot are the percentage of GFP+H-2Kb–SIIN+ cells as described in the Materials and Methods.
These data are representative of three separate experiments.
doi:10.1371/journal.ppat.1003112.g005
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EBNA1 translation and antigen presentation. The results show
that the repetitive purine-rich mRNA sequence itself is responsible
for the inhibition of EBNA1 protein synthesis and subsequent poor
immunogenicity. When taken together with other studies [12,22],
these results suggest that an unusual RNA secondary structure
within the repeat region may interfere with translation of the
EBNA1 mRNA by inhibiting ribosome transit through the purine-
rich sequence, thereby leading to a reduction in the levels of
EBNA1 such that the infected cell evades the normal host immune
surveillance mechanisms.
Comparison of the mRNA sequences of related viruses
encoding corresponding proteins responsible for maintenance of
latent infections reveals the presence of highly homologous purine-
rich repetitive sequences interspersed within the functional coding
regions of these proteins. Although highly conserved in mRNA
sequence, these repeat regions encode very different peptide
sequences in the different viruses. Moreover, substituting the
native EBNA1 mRNA repeat sequence with the purine-rich
mRNA repeat sequence from the related viral maintenance
protein Ateline herpesvirus 3 ORF73 demonstrated that the mRNA
repeat of the Ateline herpesvirus 3 ORF73 is able to inhibit both
EBNA1-GFP expression and T-cell recognition. These observa-
tions strongly support the conclusion that the purine-rich mRNA
sequence, rather than its encoded protein sequence, is responsible
for the reduced expression of these viral mRNAs. The immune
suppressive effects of these mRNA repeat sequences on antigenic
epitope generation may represent a more general immune evasive
strategy as hundreds of eukaryotic viral mRNAs have evolved with
a purine bias [39].
The loss of conservation of protein sequence in the face of
evolutionary conservation of the purine-rich mRNA sequence
needed for translational repression and avoidance of immune
surveillance may be the result of the tendency for ‘‘translational
recoding’’ or frame-shifting that has been shown to be induced by
G-rich mRNA sequences [40]. Although the overall purine-rich
mRNA repeat sequence regions are strongly conserved, such an
evolutionary mechanism would lead to random frame shifting and
different repeat protein sequences. This suggests that the repeat
sequences are subject to strong purifying selection acting at the
level of the nucleotide sequence and not the protein sequence.
Separate from the repeat region in EBNA1, there is a nuclear
localization signal, two short domains flanking the internal GAr
involved in binding to host cell chromosomes and also an
overlapping DNA-binding and dimerization domain required for
EBNA1 dimerization and binding to the OriP region of the viral
genome, [8] [41]. Therefore, it is likely that the design of this
Figure 6. T-cell recognition of 293KbC2 cells transfected with EBNA1-SIIN-GFP frameshift variants. Panels, A and B: 293kbC2 cells
expressing EBNA1-SIIN-GFP encoding either alternative repeat peptide sequences or no repeat were exposed to SIIN-specific OT-1 T-cells and then
incubated for 3 hours in the presence of brefeldin A at a responder to stimulator ratio of 5:1 (panel A) and ratios of 2.5:1–40:1 (panel B). Following
incubation, IFN-c production by OT-1 T-cells was determined by intracellular cytokine staining. The top right hand corner of the FACS plot in panel A
indicates the percentage of OT-1-specific CD8+ lymphocytes producing IFN-c. Panels, C and D: EBV-negative DG75 cells were co-transfected with
EBNA1-GFP expression constructs encoding alternative repeat peptide sequences or no repeat and a HLA B*3508-GFP expression vector. The
transfected cells were exposed to HPV-specific T-cells and incubated in the presence of brefeldin A overnight at a responder to stimulator ratio of 5:1
(panel C) and ratios of 2.5:1–20:1 (panel D). Following incubation, IFN-c production by HPV-specific T-cells was determined by intracellular cytokine
staining and shown in the top right hand corner of the FACS plot in panel C as the percentage of HPV-specific CD8+ lymphocytes producing IFN-c.
These data are representative of three separate experiments.
doi:10.1371/journal.ppat.1003112.g006
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protein serves two primary functions – viral genome maintenance
and immune evasion, with the latter involving translational
repression mediated by the repeat region mRNA sequence.
The identification of mRNA repeats which inhibit EBNA1
translational efficiency and endogenous antigen presentation
suggests a novel approach to potential new therapeutic interven-
tions involving the use of specific ‘‘antisense’’ therapeutics aimed at
the putative structures in the purine-rich mRNA sequence. Such
strategies would increase the amount of EBNA1 protein in latently
infected cells, thus facilitating normal immune recognition and
thereby elimination of the virus by the immune system.
Materials and Methods
Ethics statement
The Queensland Institute of Medical Research Ethics Commit-
tee approved all experiments (P353). All patients provided written
informed consent for the collection of blood samples and subsequent
analysis.
Cell lines
The EBV negative cell line, DG75 was maintained in RPMI
1640 supplemented with 2 mM L-glutamine, 100 IU/ml penicil-
lin, and 100 mg/ml streptomycin plus 10% FCS (referred to as
Growth Medium) and used as targets for T-cell assays. HEK293
cells stably expressing the mouse class I allele H-2Kb (293KbC2)
were maintained in DMEM supplemented with 5.56 mM D-
glucose, 4 mM L-glutamine, 1 mM sodium pyruvate, 100 IU/ml
penicillin and 100 mg/ml streptomycin plus 10% foetal calf serum
(referred to as DMEM/10FCS) and were used for EBNA1
localization studies, intracellular degradation analysis and CTL
assays.
Pair wise sequence alignments
Comparisons between the coding sequence mRNA of EBNA1
and a number of other gammaherpesvirus maintenance proteins
were performed using a pair wise sequence alignment visualized as
dot plots. The alignments were performed using zPicture, which is
a dynamic alignment and visualization tool based on the BLASTZ
alignment program [37]. The Genbank accession numbers for the
viral mRNAs were: (HHV-4) EBNA1 (NC_007605); (HHV-8)
Lana1 (U75698.1); (Papiine HV-1) baboon EBNA1 (HPU23857);
(Macacine HV-4) rhesus EBNA1 (NC_006146.1); (Alcelaphine HV-1)
ORF73 (AF005370.1); (Ovine HV-2) ORF73 (AY839756.1) and
(Saimirine HV-2) ORF73 (NC_001350.1).
Generation of EBNA1 expression constructs
An EBNA1 expression construct encoding native GAr sequence
was generated by synthesizing a 615 nucleotide DNA fragment
corresponding to EBNA1 nucleotides 209–814 and incorporating
a 39 Cla1 site (DNA 2.0, Menlo Park CA). This DNA fragment was
cloned into the Bspe1 and a mutagenized Cla1 site (position 250) of
a previously generated E1DGA/pcDNA3 expression vector [12]
to generate the expression construct E1-GA(wild-type) corre-
sponding to native EBNA1 sequence encoding a 175 amino acid
(aa) glycine/alanine repeated peptide sequence. An alternative
EBNA1 frameshift expression construct was generated by altering
the reading frame of the internal EBNA1 repeat sequence to
encode a glycine/glutamic acid/glutamine (GQE) repeated
peptide sequence (175 aa). This was achieved by synthesizing a
second DNA fragment similar to that described above but with a
single (A) nucleotide deletion at position 56 within the synthesized
DNA fragment (corresponding to EBNA1 nucleotide position 264)
to generate the expression construct E1-GQE(frameshift 1).
Likewise, a second EBNA1 frameshift expression construct was
generated to encode a glycine-arginine-serine (GRS) repeated
peptide sequence (175 aa) by synthesizing a third DNA fragment
(again similar to the first DNA fragment described above) but with
two (A) nucleotides deleted at positions 56–57 within the
synthesized DNA fragment (corresponding to EBNA1 nucleotide
positions 264–265) to generate the expression construct E1-
GRS(frameshift 2). To maintain the wildtype EBNA1 reading
frame immediately following the internal repeat, either a single (G)
nucleotide was inserted at EBNA1 nucleotide position 809 by
mutagenesis in the E1-GQE(frameshift 1) construct or two
nucleotides (AG) were inserted at EBNA1 nucleotide positions
813–814 in the E1-GRS(frameshift 2) construct. The DNA
sequences of all three frameshift expression constructs did not
encode stop codons as verified by DNA sequencing. The three
EBNA1 frameshift DNA sequences, E1-GA(wildtype), E1-GQE(-
frameshift 1) and E1-GRS(frameshift 2) in addition to E1DGA
were also sub-cloned in-frame with a sequence coding for green
fluorescent protein (pEGFP-N1, CLONTECH, Palo Alto, CA) to
generate E1-GA(wild-type)-GFP, E1-GQE(frameshift 1)-GFP, E1-
Figure 7. Localization, expression and T-cell recognition of
293KbC2 cells transfected with an EBNA1-Ateline-SIIN-GFP
expression construct. A, GFP fluorescence, DAPI staining and Flow
cytometric analysis of GFP expression in 293KbC2 cells following
transfection with an EBNA1-Ateline-SIIN-GFP expression construct. The
cells were examined using a laser-scanning Bio-Rad (Hercules, CA)
MRC600 confocal microscope with original magnification663. The Mean
Fluorescence Intensity (MFI) of the EBNA1-GFP positive cells is indicated
in the top right hand corner of the FACS plot. B, T-cell recognition of
293KbC2 cells transfected with EBNA1-SIIN-GFP variants. 293kbC2 cells
expressing EBNA1-SIIN-GFP encoding either wildtype or Ateline repeat
peptide sequences or no repeat were exposed to SIIN-specific OT-1 T-
cells and incubated for 3 hours in the presence of brefeldin A at
responder to stimulator ratios of 2.5:1–20:1. Following incubation, IFN-c
production by OT-1 T-cells was determined by intracellular cytokine
staining. These data are representative of three separate experiments.
doi:10.1371/journal.ppat.1003112.g007
mRNA Sequence Influences EBNA1 MHC I Presentation
PLOS Pathogens | www.plospathogens.org 9 December 2012 | Volume 8 | Issue 12 | e1003112
GRS(frameshift 2)-GFP and E1DGA-GFP. For the assessment of
endogenous loading of MHC class I molecules, a H-2Kb-restricted
epitope from ovalbumin, (Ser–Ile–Ile–Asn–Phe–Glu–Lys–Leu,
residues 257–264), referred to as SIINFEKL [38] was inserted
in-frame into all three EBNA1-GFP frameshift expression
constructs as well as into the E1DGA-GFP expression construct
between the 39 end of the EBNA1 sequence and the start of the
GFP sequence to generate E1-GA(wild-type)-SIIN-GFP, E1-
GQE(frameshift 1)-SIIN-GFP, E1-GRS(frameshift 2)-SIIN-GFP
and E1DGA-SIIN-GFP. Endogenous processing and surface
presentation of EBNA1 was also assessed using a second epitope
encoded within the EBNA1 sequence and restricted through HLA
B*3508, HPVGEADYFEY (His–Pro–Val–Gly–Glu–Ala–Asp–
Tyr–Phe–Glu–Tyr, residues 407–417) and referred to as HPV.
Intracellular proteasomal inhibition and degradation
studies
HEK293KbC2 cells (26105) were transiently transfected with
0.4 mg of the expression constructs E1DGA-SIIN-GFP, E1-
GA(wild-type)-SIIN-GFP, E1-GQE(frameshift 1)-SIIN-GFP or
E1-GRS(frameshift 2)-SIIN-GFP in the presence or absence of
the proteasomal inhibitor MG132 (10 mM; Merck Biosciences)
using Effectene (QIAGEN, Hilden, Germany) according to the
manufacturer’s instructions. At 24 hours post-transfection, cyclo-
heximide (50 mg/ml) was added to each sample well. Equal
aliquots of cells were trypsinized, washed and processed to
measure EBNA1-GFP expression by flow cytometry at time
points 0 h, 3 h, 6 h, 24 h and 30 h.
In vitro translation assays
EBNA1-pcDNA3 frameshift expression constructs E1-GA(wild-
type), E1-GQE(frameshift 1) and E1-GRS(frameshift 2); E1DGA
and E1-Ateline were transcribed and translated in vitro with T7
RNA polymerase using a coupled transcription/translation
reticulocyte lysate system (Promega, Madison WI) supplemented
with 10 mCi 35[S]-methionine (Perkin-Elmer Pty Ltd., Boston,
MA.). Lysates were subjected to SDS-PAGE followed by
autoradiography and band intensities were quantified by densito-
metric analysis using Imagequant software (Molecular Dynamics).
Detection of cell surface Kb-SIINFEKL
293KbC2 cells (26105), which stably express H-2Kb [38], were
transfected with 0.4 mg of the EBNA1-SIIN-GFP frameshift expres-
sion constructs using Effectene. A separate transfection of the parent
construct without SIINFEKL was also performed to provide a
negative control. Cells were harvested after an overnight transfection
and stained with mAb 25D1.16 [38] conjugated to Allophycocyanin
(Molecular Probes, Invitrogen) for 30 min at 4uC. Cells were washed
and analyzed by flow cytometry on a FACSCanto II (BD Biosciences)
for GFP expression and 25D1.16 binding.
Intracellular cytokine staining
HEK293KbC2 cells (26105) transiently transfected with
EBNA1-SIIN-GFP frameshift expression constructs (24 h) were
incubated with ovalbumin-specific T-cells (OT-1) for 3 hours at
37uC at responder to stimulator ratios of 2.5:1, 5:1, 10:1 and 20:1
and 40:1 in DMEM/10FCS medium supplemented with Brefeldin
A (BD Pharmingen, San Diego, USA). Cells were washed and
incubated with Allophycocyanin (APC)-conjugated anti-CD3 and
PerCP-conjugated anti-CD8 for 30 min, rewashed, then fixed and
permeabilized with cytofix/cytoperm (BD Pharmingen) at 4uC for
20 minutes. Cells were washed in perm/wash (BD Pharmingen),
incubated with PE-conjugated anti-IFN-c (BD Pharmingen) at
4uC for 30 mins, rewashed and analyzed for IFN-c production by
OT-1 T-cells by flow cytometry on a FACSCanto II. DG75 cells
(56106) co-transfected (24 h) with 1.2 mg of EBNA1-SIIN-GFP
frameshift expression constructs E1-GA(wild-type)-SIIN-GFP, E1-
GQE(frameshift 1)-SIIN-GFP, E1-GRS(frameshift 2)-SIIN-GFP
or E1DGA-SIIN-GFP and 0.8 mg of a HLA B*3508-GFP
expression construct using the Amaxa Cell Line Nucleofector
Kit V (Lonza, Cologne, Germany) were incubated with HPV-
specific T-cells overnight (37uC) at responder to stimulator ratios
of 2.5:1, 5:1, 10:1 and 20:1 in Growth Medium supplemented with
Brefeldin A. IFN-c production by HPV-specific T-cells was
determined by intracellular cytokine staining as described above
with FITC-conjugated anti-CD4, PerCP-conjugated anti-CD8,
APC labeled B*3508 HPV Pentamer (ProImmune, Oxford, UK)
and PE-conjugated anti- IFN-c.
Confocal microscopy analysis
HEK293KbC2 cells seeded on glass coverslips were transfected
with the EBNA1-SIIN-GFP expression constructs as described
above. At twenty-four hours post-transfection the cells were fixed
in 4% paraformaldehyde for 20 mins, washed, permeabilized in
1% Triton-X100 in PBS for 20 mins, washed and then mounted
in Pro Long Gold antifade reagent with DAPI (Molecular Probes,
Invitrogen). GFP fluorescence in cells was detected using a laser-
scanning Bio-Rad (Hercules, CA) MRC600 confocal microscope
with original magnification663.
Supporting Information
Text S1 Supporting Information including Figure S1 which
shows mRNA sequences of the relevant repeat regions of the
EBNA1 frameshift constructs and Figure S2 which shows the
protein and mRNA sequences of the EBNA1 repeat region
substituted with the Ateline herpesvirus 3 repeat region.
(DOC)
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